• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS FREE PSA ELECSYS E2G 300 V2; PROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS FREE PSA ELECSYS E2G 300 V2; PROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERS Back to Search Results
Catalog Number 08828610190
Device Problem Incorrect Measurement (1383)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/15/2021
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).Unique device identifier (udi) (b)(4).The investigation is ongoing.
 
Event Description
The initial reporter received questionable elecsys free psa immunoassay and elecsys total psa immunoassay results for one patient tested on a cobas 8000 e 801 module.The patient's elecsys free psa immunoassay results were greater than the patient's elecsys total psa immunoassay results.The patient's initial results were not reported outside the laboratory.The customer provided the samples for additional testing.The samples were tested on a cobas 8000 e 801 module, cobas e 411 immunoassay analyzer, and an outsourced cleia analyzer.The customer's e 801 module serial number was requested but not provided.
 
Manufacturer Narrative
The customer provided the patient's sample for an investigation.The investigation confirmed the customer's elecsys free psa immunoassay and elecsys total psa immunoassay results.The investigation discovered the reported results were below the stated measuring ranges.As stated in the elecsys total psa immunoassay method sheet, "measuring range 0.006-100 ng/ml." as stated in the elecsys free psa immunoassay method sheet, "measuring range 0.01-50 ng/ml." upon investigation of the patient sample, no interferent against a component of the reagent was discovered.The customer's calibration and qc results, system alarm trace, and sample pre-analytical details were requested but not provided.The investigation did not identify a product problem.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FREE PSA ELECSYS E2G 300 V2
Type of Device
PROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key11744120
MDR Text Key270209767
Report Number1823260-2021-01277
Device Sequence Number1
Product Code LTJ
Combination Product (y/n)N
PMA/PMN Number
P000027
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 07/01/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/29/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2021
Device Catalogue Number08828610190
Device Lot Number473312
Was Device Available for Evaluation? Yes
Date Manufacturer Received04/08/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age95 YR
-
-